Pretreatment of cells with 0.5 mM sodium arsenite (but not other activators of stress-activated MAP kinase cascades) prevents the activation of p21Ras and strongly suppresses the activation of c-Raf and the MAP kinase cascade by a variety of growth factors. Arsenite appears to exert its eect by preventing the guanine nucleotide exchange factor mSos from converting Ras to its active GTP-bound state. Exposure to arsenite may be a simple way of assessing whether Ras plays an essential role in mediating activation of the MAP kinase cascade by extracellular signals.
Introduction
The sustained activation of the classical mitogenactivated protein (MAP) kinase cascade is required to induce the proliferation of some cells and the dierentiation of others (Marshall, 1995) . In this pathway, growth factors trigger the dimerization and activation of their receptors leading to transphosphorylation of the receptors at several tyrosine residues (Ullrich and Schlessinger, 1990) . These phosphotyrosines then interact with proteins containing SH2 domains, two of which are the`adaptors' Grb2 and Shc (Lowenstein et al., 1992; Pellici et al., 1992; Rozakis-Adcock et al., 1992) . Grb2 is complexed to the guanine nucleotide exchange factor mSos which activates Ras (Li et al., 1993; Gale et al., 1993) . Thus the binding of Grb2 to phosphorylated receptors (and/or to the tyrosine phosphorylated form of Shc which is bound to these receptors) recruits mSos from the cytosol to the plasma membrane where it converts Ras from the inactive GDP-bound form to the active GTP-bound state (Bowtell et al., 1992) .
Ras is associated with the plasma membrane by virtue of lipid modi®cations at its C-terminus and its membrane localization is essential for activation by growth factors (Clarke, 1992) . GTP-Ras interacts with the protein kinase c-Raf, localizing the latter to the plasma membrane (Traverse et al., 1993; Leevers et al., 1994; Stokoe et al., 1994) where it becomes activated by a mechanism(s) that is(are) not yet fully understood. The activation of c-Raf then induces the sequential activation of MAP kinase kinase-1 (MKK1) and the MAP kinases MAPK1 and MAPK2 (also known as ERK1 and ERK2). When activation of the MAPKs is sustained, they translocate from the cytosol to the nucleus to regulate transcriptional events that are critical for proliferation or dierentiation (Chen et al., 1992; Traverse et al., 1992 Traverse et al., , 1994 Lenormand et al., 1993) .
After stimulation by growth factors ceases, activation of the MAP kinase cascade can be terminated in several ways. Firstly, by protein phosphatases that dephosphorylate and inactivate MKK1 and MAPKs, secondly by the GTPase activating protein (GAP) (Trahey and McCormick, 1987) that hydrolyses the GTP bound to Ras; thirdly by protein tyrosine phosphatases (PTPases) that dephosphorylate growth factor receptors and Shc. However, the activation of MAPKs can also be terminated in the continued presence of growth factors by other mechanisms. These include the induction of speci®c MAP kinase phosphatases (Alessi, 1995a) , the inactivation of MKK1 resulting from its phosphorylation at Thr-286 and Thr-292 by cyclin-dependent protein kinases (Rossomando et al., 1994) , the dissociation of GTPRas from c-Raf triggered by cyclic AMP (Wu et al., 1993) , the phosphorylation of some receptors at serine residues and, perhaps, by the phosphorylation of mSos at a serine/threonine residue(s) which may trigger dissociation of the Grb2-mSos complex from the receptor (Buday et al., 1995; Rozakis-Adcock et al., 1995 , but see Corbalan-Gracia et al., 1996 .
Stressful stimuli, such as heat shock, osmotic shock and ultraviolet radiation, activate stress activated protein (SAP) kinase cascades which operate via distinct MAP kinase family members that include SAPK2/p38 and SAPK1/JNK (reviewed in Cohen, 1997) . These SAP kinase cascades can also be triggered by exposing cells to sodium arsenite (Rouse et al., 1994) , a compound known to mimic many heat shock-induced responses (Johnston et al., 1980; Tanguay et al., 1983) . Since cell proliferation and dierentiation should be inhibited under stressful conditions to conserve nutrients and ATP for functions essential for cell survival, we investigated whether agonists that activate SAP kinases were capable of preventing activation of the classical MAPK pathway by growth factors. Here we show that suppression of the MAPK pathway does indeed occur when cells are pretreated with arsenite, but not when they are exposed to several other stresses that trigger the activation of SAP kinases. Further analysis has revealed that arsenite prevents activation of the MAP kinase cascade by blocking the activation of Ras.
Results and Discussion
Eect of sodium arsenite on the activation of the MAP kinase pathway by growth factors Pretreatment of Swiss 3T3 cells for 30 min with 0.5 mM sodium arsenite decreased by 80% the activation of MAPK2 by EGF (Figure 1b) and decreased by 90% the activation of MAPK2 by PDGF (data not shown). However, inhibition was not caused by the activation of a known SAP kinase pathway because it was not prevented by SB 203580, a speci®c inhibitor of SAPK2/p38 (Cohen, 1997) and because other stimuli that are stronger activators of SAPK2/p38 and SAPK1/JNK than arsenite (osmotic shock, UV-C irradiation or the protein synthesis inhibitor anisomycin) had no eect on the level of MAPK2 activation by EGF (data not shown).
Pretreatment with arsenite inhibited by 90% the activation of MKK by EGF (Figure 1a) , demonstrating that the suppression of MAPK activation is not explained by the induction of speci®c MAP kinase phosphatases. A similar suppression of the activation of MKK by arsenite was observed when Swiss 3T3 cells were stimulated with PDGF, when KB cells or A431 cells were stimulated with EGF, and when PC12 cells were stimulated with either EGF or NGF (data not shown), establishing that the eect of arsenite is not growth factor speci®c or cell speci®c. The eect of arsenite increased progressively with time and was maximal after 30 min in A431 cells (Figure 1c) , KB cells and PC12 cells (data not shown).
MKK1 can be inactivated by the p34cdc2-catalyzed phosphorylation of Thr-286 and Thr-292 (Wu et al., 1993) , raising the possibility that arsenite may have activated a Thr286/Thr292 kinase. This possibility was excluded ®rstly by the demonstration that MKK1 from arsenite-treated cells could be activated by c-Raf to the same level as MKK1 from untreated cells (data not shown); secondly, by the ®nding that the activation of c-Raf by EGF (Figure 2a Pretreatment with arsenite did not inhibit the fourfold activation of p70 S6 kinase induced by stimulation of A431 cells for 20 min with EGF (data not shown). On the contrary, 0.5 mM arsenite (in the absence of EGF) induced a threefold activation of p70 S6 kinase after 30 min (data not shown). The activation of p70 S6 kinase by arsenite, like the activation by EGF, was prevented by inhibitors of phosphatidylinositol (PI) 3-kinase (wortmannin, LY 294002) or by the immunosuppressant drug rapamycin. Preincubation with arsenite only decreased by 35% the 20-fold activation of PKB induced by stimulation for 5 min with IGF-1 (data not shown). These observations and the ®nding that SAP kinase cascades are activated by arsenite (Rouse et al., 1994) , demonstrates that arsenite does not have a general inhibitory eect on all kinase cascades, and eliminates the possibility that this compound exerts its eects on the Ras-MAPK pathway by depleting ATP or by a generalized toxic eect on cells.
The GTPase activator protein (GAP) inactivates p21Ras by increasing the rate of hydrolysis of the GTP which is bound to p21Ras. Therefore one way in which arsenite might prevent the activation of p21Ras would be by increasing GAP activity, thus decreasing the amount of GTP bound to Ras. However, lysates prepared from A431 cells which had been pretreated with arsenite and then stimulated with EGF did not show increased GAP activity compared to unstimulated cells (data not shown). Arsenite pretreatment also had no eect on the localization of p21Ras which remained in the membrane phase when A431 cells were lysed with Triton X-114 (data not shown).
In order to investigate further how arsenite prevents the activation of Ras, we studied the level of EGF receptor phosphorylation after pretreatment with arsenite followed by stimulation with EGF. Arsenite alone had no eect on receptor phosphorylation but, surprisingly, potentiated the level of tyrosine phosphorylation induced by EGF in Swiss 3T3 cells (Figure 3a ) and A431 cells (data not shown). Consistent with the . Con¯uent Swiss 3T3 cells were incubated for 16 h in 0.1% FBS, then treated for 28 min with (+) or without (7) 0.5 mM sodium arsenite before being stimulated for 2 min (MKK) and 5 min (MAPK) with (+) or without (7) 100 ng/ml EGF in the continued presence or absence of arsenite (see Materials and methods). The cells were lysed in`lysis buer' and MKK (a) and MAPK (b) activities measured. The results are presented as standard deviations for three experiments. (c) The experiment was carried out as in a, except that A431 cells were incubated with sodium arsenite for the times indicated prior to stimulation with EGF higher level of tyrosine phosphorylation, arsenite pretreatment greatly enhanced the association of the EGF receptor with the adaptor molecule Shc. However, the tyrosine phosphorylation of Shc induced by EGF was unaected by pretreatment of the cells with arsenite (Figure 3b) .
The GTP-GDP exchange factor which catalyzes the activation of Ras (mSos) is complexed to Grb2 and becomes competent to activate Ras when it is recruited to the plasma membrane (Aronheim et al., 1994) . This happens when EGF induces the phosphorylation of Tyr-1068 on the EGF receptor which then interacts with the SH2 domain of Grb2. We therefore studied the association of the mSos-Grb2 complex with a tyrosine phosphorylated peptide corresponding to the sequence surrounding Tyr-1068 (Buday et al., 1995) . The mSos-Grb2 complex from unstimulated cells bound tightly to this phosphopeptide and was therefore pelleted with the AGel to which the peptide was attached. Pretreatment with arsenite did not aect the interaction of the mSos-Grb2 complex with the phosphopeptide (data not shown), indicating that neither Grb2 nor mSos is modi®ed by arsenite pretreatment in a way that would prevent association of the complex with Tyr-1068.
The observation that arsenite does not aect the EGF-dependent recruitment of Grb2-mSos to the EGF receptor, indicates that mSos is unable to convert Ras to its active GTP-bound state in the presence of arsenite. This suggests that arsenite may inhibit the GTP/GDP exchange activity of mSos, either directly or indirectly by increasing the intracellular GDP : GTP ratio. However, other explanations are possible. For example, the ®nding that arsenite enhances the EGFinduced tyrosine phosphorylation of the EGF receptor (Figure 3a) suggests that arsenite inhibits one or more (7) 0.5 mM sodium arsenite before being stimulated for 2 min with (+) or without (7) 100 ng/ml EGF in the continued presence or absence of arsenite. The cells were lysed and c-Raf activity measured (see Materials and methods). (b) Same as a, except that the cells were stimulated with 0.4 mg/ml PMA instead of EGF. (c) Rat L6 myotubes were deprived of serum for 16 h and incubated for 1 h in HBS buer (see Materials and methods). Cells were treated subsequently with (+) or without (7) 0.5 mM sodium arsenite (30 min) before being stimulated for 2 min with (+) or without (7) 100 ng/ml IGF-1 in the continued presence or absence of arsenite. (d) Con¯uent cells were incubated for 16 h in phosphate-free DMEM in 0.5% phosphate-free FBS, for 4 h with [ 32 P]orthophosphate, and then for 29 min with (+) or without (7) 0.5 mM sodium arsenite before being stimulated for 1 min with (+) or without (7) 100 ng/ml EGF in the continued presence or absence of arsenite. The cells were lysed and the GTP-loading of p21Ras analysed. The ®gure shows the % GTP bound to p21Ras relative to the total guanine nucleotides (GDP + GTP) bound to p21Ras Figure 3 Eect of arsenite on the tyrosine phosphorylation of the EGF receptor and its interaction with adaptor proteins in Swiss 3T3 cells. Cells were treated for 30 min with 0.5 mM sodium arsenite and stimulated for 2 min with 100 ng/ml EGF as in Figure 1 and the EGF receptor (EGFR) (a) or Shc isoforms (b) immunoprecipitated (IP) from the lysates (0.3 mg protein in a and 0.2 mg protein in b), dissolved in SDS and subjected to polyacrylamide gel electrophoresis. After transfer to nitrocellulose, the ®lter was blotted with antiphosphotyrosine antibodies (pY blot) protein tyrosine phosphatases (PTPases). Figure 4 demonstrates that this is indeed the case. Three PTPases (PTP-1B, SHP1 and SHP2) were all found to be strongly inhibited in vitro by mM concentrations of arsenite. SHP2 is an SH2-domain-containing PTPase that binds to phosphotyrosine residues on growth factor receptors and appears to play a role in the activation of the MAPK cascade because the overexpression of a dominant negative mutant inhibits growth factor-induced activation of MAPK (Xiao et al., 1994; Milarski and Saltiel, 1995; Rivard et al., 1995; Tang et al., 1995; Ali et al., 1996) . However, SHP2 activity was only inhibited 50% at 0.5 mM arsenite (Figure 4) , a concentration at which the EGF-induced GTP-loading of Ras was suppressed by 80 ± 90% (Figure 2d) .
Although further work is needed to understand how arsenite suppresses the activation of Ras, our results suggest that arsenite is a useful reagent for investigating the involvement of Ras in the activation of c-Raf and the MAPK pathway by any particular agonist. For example, the ®nding that arsenite abolishes the activation of c-Raf by PMA in Swiss 3T3 cells (Figure 2b ) is consistent with an essential role for Ras in the activation of c-Raf by phorbol esters. In L6 myotubes, the IGF-1 induced activation of c-Raf, MKK1 and MAPK is suppressed by wortmannin and/ or LY 294002, indicating that a phosphatidylinositide (PtdIns) 3-kinase plays an essential role in the activation of c-Raf by this growth factor (Cross et al., 1994) . However, the IGF1-induced GTP-loading of Ras is unaected by wortmannin (Cross et al., 1994) , demonstrating that PtdIns 3-kinase activity is not rate limiting for the activation of Ras in these cells. In the present study, we found that pretreatment of L6 myotubes with arsenite virtually abolishes IGF-1 induced activation of c-Raf (Figure 2c ) without aecting the activation of PtdIns 3-kinase (as shown by the continued activation of PKB). Thus Ras and PtdIns 3-kinase both play essential but independent roles in the IGF-1 induced activation of cRaf..
Materials and methods

Materials
Monoclonal anti-Ras antibodies for immunoblotting and anti-phosphotyrosine antibodies (PY20) were from Transduction Laboratories (Lexington, USA), polyclonal antibodies raised against human Shc and mouse Sos1 were from UBI (Lake Placid, USA) and polyclonal antibodies raised against the human EGF receptor were from Santa Cruz Biotechnology (California, USA). Monoclonal antiRas antibodies for immunoprecipitation were a gift from Dr A. Magee (NIMR, London), while anti-c-Raf antibodies (Alessi et al., 1995b) and anti-p70 S6 kinase antibodies (Baxter et al., 1995) were produced in the MRC Unit as described previously. PTPase-1B and SHP-2 were generous gifts from Dr D Barford (University of Oxford, UK) and Drs D Cool and N Tonks (Cold Spring Harbor Laboratory, USA) respectively. SHP-1 bound to agarose was purchased from UBI. PMA, sodium arsenite and wortmannin were purchased from Sigma, EGF from Boehringer, NGF, IGF-1 and myelin basic protein from Gibco/BRL and Mono Q and protein G-Sepharose from Pharmacia.
Cell culture and cell lysis
Swiss 3T3 and A431 cells were cultured in Dulbecco's Modi®ed Eagle's Medium (DMEM) containing 10% foetal bovine serum (Gibco/BRL) and 2 mM L-glutamine in either 90% air/10% CO 2 (Swiss 3T3) or 95% air/5% CO 2 (A431 cells) and then incubated for 16 h in 0.1% foetal bovine serum (FBS). Con¯uent cells were then treated for 28 min with (+) or without (7) 0.5 mM sodium arsenite before stimulation for 2 min with (+) or without (7) 100 ng/ml EGF or 0.4 mg/ml PMA in the continued presence of arsenite. Each dish of cells was lysed in 20 mM Tris-HCl pH 7.5, 0.27 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM NaVO 3 , 10 mM sodium b-glycerophosphate pH 6.8, 50 mM NaF, 1% Triton X-100, 5 mM Na-PPi, 0.1% (by vol) 2-mercaptoethanol, 0.2 mM phenylmethylsulphonyl¯uoride (termed lysis buer) and centrifuged at 13 000 g for 10 min at 48C. The supernatant, termed cell lysate was frozen in liquid nitrogen and stored at 7808C until use.
Monolayers of L6 cells were grown to the stage of myotubes (Mitsumoto and Klip, 1992; Hundal et al., 1992) , then starved for 16 h using serum-free aMEM. The cells were then incubated for 1 h in 20 mM HEPES/NaOH pH 7.4/ 0.14 M NaCl/5 mM KCl/25 mM MgSO 4 /1 mM CaCl 2 /25 mM glucose (HBS buer) and treated with or without sodium arsenite as for Swiss 3T3 and A431 cells, before stimulation with IGF-1 (100 ng/ml).
Immunoprecipitation of protein kinases
c-Raf was immunoprecipitated from 0.4 mg of cell lysate (Alessi et al., 1995b) and p70 S6 kinase from 0.2 mg of cell lysate (Baxter et al., 1995) as described previously.
Assay of protein kinases
c-Raf, MKK and MAPK were assayed as described previously (Alessi et al., 1995c) . c-Raf was measured by its ability to activate MKK1 in a coupled assay containing MKK1 and its substrate p42 MAPK. One Unit of c-Raf was that amount which increased the activity of p42 MAPK by 1 unit/min. MKK was assayed by the activation of bacterially expressed p42K. One unit of MKK (U) was that amount which increased the activity of p42 MAPK by 1 unit/min. MAPK was assayed by its ability to phosphorylate myelin basic protein and p70 S6 kinase by its ability to phosphorylate the peptide KRRRLASLAA (Baxter et al., 1995) and one unit of activity was that amount which catalyzed the phosphorylation of 1 nmol of substrate in 1 min.
In order to measure MKK and MAPK in cell lysates, 0.3 mg of lysate was chromatographed on a 0.1 ml column of Mono Q (Baxter et al., 1995) and fractions (0.1 ml) collected and assayed for MKK and MAPK activity. The activities of the two peaks of MKK were combined to give the total MKK activity. Similarly the MAPK activity recovered from the Mono Q column as either one (A431 and Swiss 3T3 cells) or two (PC12 cells) peaks was integrated to give the total MAPK activity.
Measurement of guanine nucleotides bound to Ras
Each 6 cm dish of con¯uent Swiss 3T3 cells were deprived of serum and labelled for 16 h in phosphate free DMEM including 25 mM HEPES pH 7.4, 2 mM pyruvic acid and 1 mCi/ml 32 P-labelled sodium orthophosphate. After stimulation, the cells were washed twice with ice cold PBS and each dish lysed in 0.4 ml of lysis buer containing 0.1 mM GTP, 0.1 mM GDP, 1 mM ATP, 0.04 ml of antiRas antiserum and 0.016 ml of a complete proteinase inhibitor cocktail (Boehringer). The lysate was centrifuged for 10 min at 13 000 g at 48C, and the supernatant transferred to a fresh tube containing 10 ml lysis buer and 10 ml of packed protein G-sepharose. After shaking for 1 h at 48C, the suspensions were centrifuged and immunoprecipitates washed 10 times with 1 ml of 50 mM HEPES pH 7.4, 0.5 M NaCl, 5 mM MgCl 2 , 0.1% Triton X-100, 0.005% SDS, 0.1% 2-mercaptoethanol, with vortexing between each wash. The supernatant was removed after the last wash and Ras eluted from the beads by heating for 20 min at 708C in 20 ml of 2 mM EDTA pH 8.0, 2 mM dithiothreitol and 0.2% (by mass) SDS. An aliquot of the supernatant (10 ml) was added to 2 ml of unlabelled 0.1 mM GTP-0.1 mM GDP in water and guanine nucleotides were separated by thin layer chromatography and analysed on a phosphorimager (Klarlund et al., 1995) .
Measurement of GAP activity
GAP activity in cell lysates was measured using bacterially expressed Ras labelled with a-32 P-GTP as described (Downward, 1995) . Brie¯y, [a- 32 P]GTP-loaded Ras was incubated for 20 min at 208C with dierent amounts of cell lysate, and then immunoprecipitated. After washing four times with 1 ml of 50 mM HEPES pH 7.4, 0.5 M NaCl, 5 mM MgCl 2 , 0.1% Triton X-100, 0.005% SDS, 0.1% 2-mercaptoethanol, the guanine nucleotides associated with Ras were analysed as described above.
Membrane association of Ras
Cells were lysed in 1 ml of 50 mM Tris-HCl pH 7.4, 0.1 M NaCl, 5 mM MgCl 2 , 1 mg/ml bovine serum albumin (BSA), 1 mM sodium phosphate pH 7.4 and 1% Triton X-114 and centrifuged at 13 000 g for 10 min at 48C. The supernatant was removed, stored for 5 min at 208C, then heated for 2 min at 308C in the presence 80 ml of 5 M NaCl. The lysate was placed in ice and centrifuged for 10 s at 13 000 g. The upper cytoplasmic phase was collected, the lower membrane phase resuspended in 0.3 ml of the Triton X-114 containing lysis buer and the Ras present in both phases was analysed by immunoblotting.
Interaction of mSos with phosphotyrosine 1068 of the EGF receptor
Cells were incubated for 30 min with (+) or without (7) 0.5 mM sodium arsenite. The cell lysates (0.5 mg protein) were then shaken for 60 min at 48C with 5 mg of a phosphotyrosine containing peptide corresponding to the amino acid sequence surrounding Tyr-1068 of the EGF receptor which had been bound to 5 ml of AGel-10 ( Buday et al., 1995) . After washing four times with lysis buer, proteins were released from the peptide-AGel beads by heating for 2 min in 1% SDS at 1008C and separated by electrophoresis on a 7.5 ± 15% gradient polyacrylamide gel. The proteins were transferred to nitrocellulose and the ®lter blotted with anti-mSos antibodies.
Assay of protein tyrosine phosphatases
PTPases were diluted in 50 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.2 mM EDTA, 50 mM KCl, 1 mg/ml BSA, 0.1% (by vol) 2-mercaptoethanol and 0.2 mM phenylmethylsulphonyl¯uoride. 10 ml of diluted phosphatase was then incubated for 30 ± 60 min at 308C with 50 mM paranitrophenyl phosphate in phosphatase dilution buer. The reaction was stopped by the addition of 1 ml of 1 N NaOH and, after standing for 10 min at ambient temperature, the absorbance at 405 nm was recorded. Under the assay conditions employed the dephosphorylation of para-nitrophenylphosphate was linear with respect to time and enzyme concentration.
